Investors Purchase Large Volume of Siga Technologies Call Options (NASDAQ:SIGA)

Siga Technologies Inc. (NASDAQ:SIGA) saw some unusual options trading activity on Wednesday. Traders acquired 1,200 call options on the stock. This represents an increase of approximately 1,438% compared to the typical volume of 78 call options.

Hedge Funds Weigh In On Siga Technologies

Several institutional investors and hedge funds have recently modified their holdings of SIGA. Farther Finance Advisors LLC increased its stake in shares of Siga Technologies by 418.1% in the fourth quarter. Farther Finance Advisors LLC now owns 4,150 shares of the company’s stock worth $25,000 after acquiring an additional 3,349 shares during the last quarter. BNP Paribas Financial Markets grew its stake in Siga Technologies by 34.1% in the second quarter. BNP Paribas Financial Markets now owns 4,661 shares of the company’s stock valued at $30,000 after purchasing an additional 1,184 shares in the last quarter. CWM LLC increased its position in Siga Technologies by 148.6% in the 4th quarter. CWM LLC now owns 5,027 shares of the company’s stock worth $31,000 after purchasing an additional 3,005 shares during the last quarter. State of Alaska Department of Revenue purchased a new stake in shares of Siga Technologies during the 3rd quarter worth about $34,000. Finally, Tower Research Capital LLC TRC raised its stake in shares of Siga Technologies by 116.6% during the 2nd quarter. Tower Research Capital LLC TRC now owns 6,817 shares of the company’s stock worth $44,000 after purchasing an additional 3,669 shares in the last quarter. 55.40% of the stock is currently owned by hedge funds and other institutional investors.

Siga Technologies Price Performance

NASDAQ SIGA opened at $6.24 on Friday. The firm has a market capitalization of $446.85 million, a price-to-earnings ratio of 6.12 and a beta of 0.97. The company has a 50 day simple moving average of $6.60 and a 200-day simple moving average of $7.32. Siga Technologies has a 52-week low of $4.95 and a 52-week high of $9.62.

Analyst Upgrades and Downgrades

SIGA has been the subject of several recent research reports. Weiss Ratings lowered shares of Siga Technologies from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Monday, January 26th. Wall Street Zen cut Siga Technologies from a “strong-buy” rating to a “hold” rating in a report on Saturday, November 15th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company currently has an average rating of “Sell”.

About Siga Technologies

Siga Technologies, Inc (NASDAQ: SIGA) is a specialty pharmaceutical company focused on the development, manufacturing and commercialization of medical countermeasures for public health emergencies and biological threats. The company’s flagship product, TPOXX® (tecovirimat), is the first and only antiviral approved by the U.S. Food and Drug Administration for the treatment of smallpox. Siga has entered into procurement and development contracts with U.S. government agencies, including the Biomedical Advanced Research and Development Authority (BARDA) and the Department of Defense, to supply TPOXX® for the Strategic National Stockpile.

Founded in 2002, Siga has built a pipeline of therapies targeting high-consequence pathogens such as smallpox, plague and other potential biothreat agents.